|
Audience: This activity is intended for
healthcare professionals practicing in managed care environments.
This activity is supported by an
educational grant from GlaxoSmithKline
PLEASE CLICK HERE TO VIEW PRESENTATION
PLEASE CLICK HERE FOR POST TEST AND
EVALUATION
Instructions for CME/CEU: View the presentation, answer the
post test, complete the evaluation form and submit to
keads@namcp.org. You will
have the option on the post test/evaluation page to submit your
forms electronically or by faxing them to Katie Eads at
804-747-5316.
Summary
Patient
compliance and behavior modification is all part of treating any
disease state. When modification is not enough, pharmacological
treatment is necessary. This session will provide you with knowledge
on when to go beyond behavior modification straight to
pharmacological options.
Objectives
-
Describe the health
implications for patients with diabetes
-
Discuss behavior
modifications for diabetic patients
-
Evaluate treatment
options when behavior changes are not enough
|
Faculty: |
Zachary T. Bloomgarden, MD,
Clinical Professor, Mount Sinai School of Medicine, New
York, NY |
| |
|
|
Disclosure:
|
Dr. Bloomgarden serves on
the speakers bureau for Merck, Nov Nordisk, Eli Lilly/Amylin
and serves as a consultant to Takeda. Dr. Bloomgarden’s
wife is a stockholder/consultant to Novartis. |
Accreditation & Designation
The National Association of Managed
Care Physicians (NAMCP) is accredited by the Accreditation Council
for Continuing Medical Education to sponsor continuing medical
education for physicians. NAMCP designates this activity for a
maximum of 1 AMA PRA Category I creditsTM. Each physician should
claim credit commensurate with the extent of their participation in
the activity.
The American Association of Managed Care Nurses (AAMCN) has been
approved as a provider of continuing education by the Virginia
Nurses Association (VNA) VNA is accredited as an approver of
continuing education in nursing by the American Nurses Credentialing
Center’s Commission on Accreditation. Nurses who complete this
activity will be awarded 1.0 contact hours.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
requirements.
This activity is
supported by an educational grant from GlaxoSmithKline
|